cannula_drift
TL3 Regular · Sarajevo, BA
Long-standing member. Posts carefully and infrequently, mostly in the practice and analytics categories.
Joined 8 August 2024 · last posted 2d
124 posts, newest first. Showing up to 150.
-
Request: a per-category review queue Replied, post #133 · Meta › Feature requests · 26 Jul 2026 · 6 likes I read post #132 twice before replying, because I had assumed the opposite. Community support: if other people support your request, they can reply with "+1" or "I…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #22 · Compounds › Oral incretins · 24 Jul 2026 · 19 likes Taking post #19 at face value and following it one step further. My position on PIONEER 6 cardiovascular safety is current rather than settled. I have revised it once…
-
Priming a pen and whether the primed volume is wasted Replied, post #18 · Devices › Pens & autoinjectors · 22 Jul 2026 · 4 likes A pen taken straight from the refrigerator is uncomfortable to inject for the same reason a cold syringe is. Room temperature for a short while first is the standard…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #66 · Start Here › Welcome · 21 Jul 2026 · 3 likes Small correction to my own earlier position on Reading order. I had the units the wrong way round, which changes the conclusion by an order of magnitude and therefore…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #93 · Evidence › Journal club · 21 Jul 2026 · 18 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Pages past their review date, listed — does this still hold? Replied, post #56 · Meta › Wiki maintenance · 17 Jul 2026 · 0 likes Thank you for the correction. I would rather find out here than later.
-
Why 99.2% and 97.8% on the same lot can both be correct Replied, post #18 · Analytics › HPLC & UHPLC · 16 Jul 2026 · 1 like Two people in this thread mean different things by 99.2% and 97.8% and are disagreeing about the definition while believing they are disagreeing about the facts. Worth…
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #85 · Wellbeing › Sleep · 14 Jul 2026 · 22 likes Sleep-disordered breathing improving with weight reduction is one of the better-evidenced downstream effects, and the trial that measured it used an objective index…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #41 · Compounds › Secretagogues & GH axis · 10 Jul 2026 · 0 likes The arithmetic in post #38 is right; the assumption feeding it is the part to check. On GHRH analogues versus ghrelin mimetics, the part that usually goes wrong is that…
-
Submitting a sample: the process end to end Replied, post #70 · Sourcing › Independent verification · 9 Jul 2026 · 0 likes Submitting a sample is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with boring.
-
Immortal time bias in a claims-database study — one year on Replied, post #14 · Evidence › Study critique · 9 Jul 2026 · 4 likes Immortal time bias is worth one more sentence than it usually gets, and the sentence is the one about how the number was arrived at.
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #110 · Outcomes › Body composition · 7 Jul 2026 · 4 likes Taking post #107 at face value and following it one step further. Photographs under fixed lighting and posture are a genuine record and are the hardest of these to…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #38 · Practice › Dosing & titration · 4 Jul 2026 · 23 likes Confirming post #35 from a second method, which matters more than confirming it from a second person. Concentration and dose get conflated constantly in this…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #85 · Start Here › How to Ask · 30 Jun 2026 · 3 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #4 · Analytics › HPLC & UHPLC · 30 Jun 2026 · 0 likes The arithmetic in post #2 is right; the assumption feeding it is the part to check. The honest answer on Detection wavelength is that it depends, and the useful part is…
-
Athletes in weight-category sports: a different risk calculus Replied, post #7 · Clinical › Special populations · 29 Jun 2026 · 23 likes Post #3 put the caveat in the right place and I want to underline it. Body weight at the extremes of the studied range affects exposure and the trials rarely reported…
-
Racemisation and why it is invisible to a mass measurement — what changed since Replied, post #13 · Analytics › Impurities & related substances · 26 Jun 2026 · 5 likes Taking post #10 at face value and following it one step further. Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method.…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #66 · Start Here › How to Ask · 24 Jun 2026 · 32 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. If that is already documented…
-
Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #23 · Compounds › Semaglutide · 23 Jun 2026 · 18 likes The oral formulation is a genuinely different pharmaceutical problem from the injectable and shares only the active molecule. Absorption enhancers, fasting requirements…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #21 · Analytics › Home & field testing · 23 Jun 2026 · 1 like What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds…
-
Tracking intake honestly when appetite is absent Replied, post #70 · Nutrition & Training › Protein & intake · 23 Jun 2026 · 9 likes Answering the question post #66 raises rather than the one it answers. What I would want before treating tracking intake as settled: the method, the sample, and whether…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #23 · Pharmacology › Receptor biology · 21 Jun 2026 · 8 likes Receptor distribution explains the side-effect profile better than anything else. GLP-1 receptors in the gastrointestinal tract and the area postrema account for most…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Started this topic · Compounds › Secretagogues & GH axis · 17 Jun 2026 · 0 likes Reading a rodent study on a secretagogue without over-extrapolating — the long version — setting out what I have, and where I think it stops being reliable. A narrow…
-
What a certificate commits its issuer to — one year on Replied, post #89 · Analytics › COA interpretation · 15 Jun 2026 · 17 likes Taking post #87 at face value and following it one step further. A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #39 · Compounds › Repair & healing peptides · 9 Jun 2026 · 0 likes Coming back to post #35, because the follow-up matters more than the original answer. Mechanistic accounts in this area run well ahead of the outcome data. Angiogenesis…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #95 · Sourcing › Logistics · 8 Jun 2026 · 5 likes Narrowing post #94, because the general version has more than one answer. Import restrictions by jurisdiction: what is legal to import for personal use varies…
-
The headache that turns out to be dehydration — the long version Replied, post #45 · Nutrition & Training › Hydration & electrolytes · 3 Jun 2026 · 22 likes The most useful posts here describe what was measured, what was changed, and what happened, in that order. The uncertainty is in the assumption, not in the calculation.
-
Follow-up: Sleep quality changes during weight loss Replied, post #34 · Wellbeing › Sleep · 31 May 2026 · 27 likes Taking post #33 at face value and following it one step further. Sleep quality changes reported here have several plausible contributors, and separating drug effects…
-
Revisiting: The arithmetic of an intermediate dose between two label steps Replied, post #45 · Practice › Dosing & titration · 22 May 2026 · 0 likes Post #43 and I disagree about the size of the effect, not about the direction. Dose and effect are not linear across the studied range for every compound in this class.…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #49 · Meta › Announcements · 19 May 2026 · 32 likes The confident answers on Trust level 3 requirements and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this…
-
Delayed gastric emptying and oral medication absorption: which drugs matter — one year on Replied, post #4 · Practice › Interactions · 18 May 2026 · 6 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #26 · Compounds › Repair & healing peptides · 16 May 2026 · 0 likes For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence of published clinical work. It does not endorse or…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #38 · Practice › Administration · 9 May 2026 · 0 likes I have been on both sides of the completing a dose argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
-
Request: show the solution author in the topic list — what changed since Replied, post #87 · Meta › Feature requests · 4 May 2026 · 14 likes Post #85 and I disagree about the size of the effect, not about the direction. Effort estimation: some features are trivial to implement; others are substantial work.…
-
Journal club: is percentage weight change the right endpoint? Replied, post #104 · Evidence › Journal club · 25 Apr 2026 · 21 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #7 · Evidence › Journal club · 22 Apr 2026 · 13 likes Narrowing post #6, because the general version has more than one answer. The figures usually contain the finding and the text usually contains the interpretation.…
-
Coming back to: Measurement error in a self-reported exposure Replied, post #5 · Evidence › Study critique · 20 Apr 2026 · 6 likes Post #2 put the caveat in the right place and I want to underline it. Two claims get bundled together under Measurement error and they need separating. The descriptive…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? Replied, post #4 · Sourcing › Independent verification · 16 Apr 2026 · 6 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Five questions in one post gets you one answer — how to split them Replied, post #54 · Start Here › How to Ask · 13 Apr 2026 · 0 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
-
Reading a syringe in poor light, and how to avoid needing to — what changed since Replied, post #4 · Devices › Syringes & needles · 13 Apr 2026 · 11 likes Post #2 describes the usual case. This is about the unusual one. U-100 means the barrel is graduated for a solution containing one hundred units of insulin per…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #67 · Analytics › Mass spectrometry · 9 Apr 2026 · 27 likes Post #64 is the version of this I will quote in future. One addition. Charge states observed: for semaglutide (4113.6 Da) the doubly charged ion appears at m/z ≈ 2057,…
-
Area percent versus weight percent: the confusion that causes most arguments Replied, post #3 · Analytics › HPLC & UHPLC · 8 Apr 2026 · 19 likes Typical suitability criteria are a replicate area relative standard deviation below about two per cent, a tailing factor inside a defined window, a resolution minimum…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #63 · Practice › Administration · 6 Apr 2026 · 17 likes On post #61 — agreed on the reasoning, with one qualification. Leaving the needle in for a couple of seconds after depressing the plunger reduces leakage at the site.…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #6 · Data & Tools › Calculators · 31 Mar 2026 · 30 likes Post #3 is the version of this I will quote in future. One addition. The most common input error is entering the vial mass in the concentration field. It produces a…
-
The "under review" status pill and when a moderator applies it Replied, post #32 · Evidence › Preprints · 22 Mar 2026 · 13 likes Media coverage of preprints rarely mentions the status. That is where most of the downstream confusion in this subcategory originates. I would rather post the…
-
Coming back to: Swirling versus inverting versus leaving it alone Replied, post #4 · Practice › Reconstitution · 22 Mar 2026 · 22 likes Swirling versus inverting versus leaving looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not…
-
Preprint servers and what screening they do Replied, post #81 · Evidence › Preprints · 8 Mar 2026 · 22 likes Whatever the answer on preprint servers turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #11 · Sourcing › Red flags · 1 Mar 2026 · 0 likes Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #39 · Research Methods › Statistics · 24 Feb 2026 · 1 like I had written a reply contradicting post #37 and deleted it. Here is what survived. For anyone finding this later: the short answer on Measurement error in home scales…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #89 · Access › Pricing · 14 Feb 2026 · 2 likes Pharmacy acquisition cost: a pharmacy pays less than the patient pays, even at insurance rates. That margin is where the pharmacy's costs and profit live. This is the…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #4 · Analytics › Mass spectrometry · 11 Feb 2026 · 20 likes Taking the opening post at face value and following it one step further. A definition problem is doing most of the work in this mass error in ppm discussion. Once the…
-
Amylin receptor signalling and satiety — what changed since Replied, post #28 · Pharmacology › Receptor biology · 10 Feb 2026 · 0 likes Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
-
A plateau that disappeared when I changed how I measured Replied, post #11 · Outcomes › Progress reports · 27 Jan 2026 · 8 likes On post #9 — agreed on the reasoning, with one qualification. Recording the dose alongside the weight makes the series interpretable later. Without it a plateau at a…
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #10 · Compounds › Semaglutide · 19 Jan 2026 · 0 likes The arithmetic in post #8 is right; the assumption feeding it is the part to check. On alcohol: the labelling does not contraindicate it, but it raises gastric…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #15 · Pharmacology › Pharmacokinetics · 14 Jan 2026 · 20 likes Post #13 describes the usual case. This is about the unusual one. Where I have landed on Washout, having got it wrong once in public: the direction is clear, the…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #41 · Access › Pricing · 20 Dec 2025 · 11 likes A price well below the rest of the market is a fact rather than a finding, and it is worth noting without concluding from it. That is what the documentation says. What…
-
Guidelines revision: what changed and why — one year on Replied, post #46 · Meta › Announcements · 14 Dec 2025 · 22 likes The edit is clearer. For anyone arriving now, read the edited version — the confusion in the replies above is about wording that no longer exists.
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #77 · Compounds › Tirzepatide · 11 Dec 2025 · 33 likes On Tirzepatide in type 2 diabetes I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #64 · Compounds › Semaglutide · 8 Dec 2025 · 5 likes Research-use-only semaglutide is not a licensed medicine, is not manufactured to pharmaceutical standards, and is not approved for human use. That is a statement about…
-
A parcel stationary at a customs facility for nine days Replied, post #10 · Sourcing › Logistics · 7 Dec 2025 · 22 likes A tracking gap at a customs facility is the most common cause of an unexpectedly long transit and the segment nobody has visibility of. If this contradicts something…
-
Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA Replied, post #9 · Compounds › Tirzepatide · 28 Nov 2025 · 3 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #96 · Practice › Reconstitution · 27 Nov 2025 · 0 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. Marking that…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #75 · Practice › Reconstitution · 26 Nov 2025 · 26 likes The arithmetic in post #73 is right; the assumption feeding it is the part to check. The lyophilised cake should be inspected before anything is added. A shrunken,…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #55 · Practice › Interactions · 23 Nov 2025 · 0 likes A pharmacist can answer most questions in this subcategory in a few minutes with access to a proper interaction database, and that access is the thing a forum does not…
-
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #8 · Safety › Contraindications · 20 Nov 2025 · 32 likes Thank you for the correction. I would rather find out here than later.
-
[2026 update] What steady state means for the decision to escalate Replied, post #44 · Practice › Dosing & titration · 9 Nov 2025 · 5 likes I have been on both sides of the steady state argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
-
Follow-up: Why appetite effects are mostly central Replied, post #84 · Pharmacology › Receptor biology · 2 Nov 2025 · 31 likes What I would check first on appetite effects is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #28 · Start Here › How to Ask · 26 Oct 2025 · 0 likes "Has anyone had this happen" gets you anecdotes. "What would cause this, and what would distinguish the causes" gets you an explanation. The second question is almost…
-
EMA product information as a primary source Replied, post #3 · Regional › European Union · 25 Oct 2025 · 20 likes Adding the measurement that the opening post says would settle it. Members outside the union should note that essentially none of this transfers, including the parts…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #113 · Analytics › HPLC & UHPLC · 19 Oct 2025 · 17 likes Adding what did not work for me on Resolution and tailing factor, since the failures never get written up and they are half the useful information.
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #99 · Lounge › Off topic · 15 Oct 2025 · 23 likes Something I have wondered without ever asking: is there a good reason the vocabulary in this field is so inconsistent between suppliers? Half the disagreements here…
-
Which panel is worth repeating and which is worth ignoring Replied, post #133 · Clinical › Bloodwork · 9 Oct 2025 · 24 likes Reframing panel slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is "how often",…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #40 · Compounds › Oral incretins · 20 Sep 2025 · 0 likes Anyone comparing published oral and injectable efficacy should check whether the comparison is within one trial or across two. Across two, the populations differ and…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #124 · Access › Insurance & coverage · 18 Sep 2025 · 1 like Adding the measurement that post #123 says would settle it. A well-written denial is genuinely useful because it tells you exactly what to submit next. A vague one is…
-
Hypertension improvement and when medication needs revisiting Replied, post #59 · Clinical › Comorbidities · 14 Sep 2025 · 16 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Documenting an adverse event properly Replied, post #6 · Safety › Adverse events · 13 Sep 2025 · 0 likes Where I part company with post #4, and it is a narrow parting. How to document: date, exact symptom or event, severity, duration, outcome, any medical attention sought.…
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #54 · Practice › Reconstitution · 11 Sep 2025 · 4 likes Research-use-only material reconstituted at home is not a compounded sterile preparation and nothing about the procedure makes it one. Members describing what they do…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #89 · Evidence › Trials · 9 Sep 2025 · 7 likes Building on post #86 rather than restating it. Number needed to treat is only interpretable with the duration attached. The same NNT over one year and over five years…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #33 · Evidence › Journal club · 20 Aug 2025 · 0 likes The version of orforglipron phase 2 that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #15 · Devices › Pens & autoinjectors · 19 Aug 2025 · 7 likes Post #11 put the caveat in the right place and I want to underline it. Off-label dosing with a pen: if you want to deliver a dose different from the pen's pre-set steps…
-
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #29 · Analytics › Mass spectrometry · 18 Aug 2025 · 0 likes A mass match establishes that the measured mass is consistent with the proposed composition. It does not establish purity, sequence order, or the absence of an isomer,…
-
A request that was declined, and the reasoning — a second dataset Replied, post #87 · Documentation › Wiki requests · 14 Aug 2025 · 2 likes Second this, and I would have said it less carefully.
-
What this community means by "a source", in practical terms Replied, post #66 · Start Here › Welcome · 10 Aug 2025 · 1 like The tag pages are usually a better entry point than the categories for a first read. A tag cuts across categories, so following one shows you how the same subject is…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #150 · Devices › Cold chain · 26 Jul 2025 · 20 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Regional warehouse stock versus direct despatch Replied, post #7 · Sourcing › Logistics · 24 Jul 2025 · 0 likes The arithmetic in post #4 is right; the assumption feeding it is the part to check. The practical version of regional warehouse stock versus direct is three sentences…
-
Sodium, potassium and magnesium when intake drops Replied, post #33 · Nutrition & Training › Hydration & electrolytes · 27 Jun 2025 · 22 likes Post #29 describes the usual case. This is about the unusual one. One more thing on sodium that took me far too long to see: the two figures people quote are not…
-
Second pass at: Trial registration and comparing the protocol with the paper Replied, post #34 · Evidence › Trials · 15 Jun 2025 · 12 likes The arithmetic in post #32 is right; the assumption feeding it is the part to check. Where the Trial registration discussion usually stalls is that nobody wants to say…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #53 · Access › Insurance & coverage · 10 Jun 2025 · 2 likes Trying to state the appeal position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that test.
-
Follow-up: Retatrutide phase 2 in type 2 diabetes: the Lancet paper Started this topic · Compounds › Retatrutide · 29 May 2025 · 39 likes Retatrutide phase 2 in type 2 diabetes: the Lancet paper Writing it up because I had to work it out twice and would rather nobody else did. A follow-up question about…
-
Vagal afferents and the gut-brain pathway Replied, post #5 · Pharmacology › Receptor biology · 24 May 2025 · 14 likes What I would check first on vagal afferents is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.
-
Pregnancy as an absolute contraindication Replied, post #75 · Safety › Contraindications · 19 May 2025 · 15 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Anxiety in the first weeks: drug, situation, or both Replied, post #90 · Wellbeing › Mental health · 18 May 2025 · 2 likes Everything in post #88 holds. The case it does not cover is the one I have. Motivation and expectation: starting with clear motivation and realistic expectations about…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #7 · Evidence › Journal club · 17 May 2025 · 7 likes The thing about CagriSema phase 2 combination paper that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look,…
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #42 · Compounds › Cagrilintide & amylin analogues · 14 May 2025 · 22 likes Published human data on cagrilintide alone is thinner than on the combination, which is the reverse of what most people assume from how it is discussed here.
-
A claim built entirely on a subgroup analysis Replied, post #32 · Evidence › Study critique · 13 May 2025 · 0 likes Statistical significance and clinical importance are different and both are needed. A significant difference below the minimal important difference is a real finding of…
-
Counter-ion content and its effect on measured mass Replied, post #32 · Analytics › Mass spectrometry · 5 May 2025 · 6 likes Sample preparation for mass spectrometry can itself introduce modifications, particularly oxidation. A finding at trace level may be telling you about the preparation…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #97 · Compounds › Cagrilintide & amylin analogues · 13 Apr 2025 · 0 likes Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and its poor adherence was a known limitation. A weekly…
-
Ipamorelin selectivity claims and where they came from Replied, post #28 · Compounds › Secretagogues & GH axis · 12 Apr 2025 · 3 likes Confirming post #26 from a second method, which matters more than confirming it from a second person. Ipamorelin selectivity claims originate in preclinical…
-
Carryover and the ghost peak from last week's standard Replied, post #83 · Analytics › HPLC & UHPLC · 11 Apr 2025 · 1 like Worth stating the null on carryover before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
-
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #49 · Compounds › Semaglutide · 23 Mar 2025 · 8 likes On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #72 · Compounds › Cagrilintide & amylin analogues · 26 Feb 2025 · 32 likes Where I part company with post #68, and it is a narrow parting. An update on my earlier amylin analogue mechanism post: the pattern held for another six weeks and then…
-
Ipamorelin selectivity claims and where they came from Replied, post #15 · Compounds › Secretagogues & GH axis · 22 Feb 2025 · 13 likes Why this subcategory is stricter about sourcing than most: the evidence base is weaker and that is precisely why documentation quality matters more. A supplier page…
-
Validating a method you did not develop — does this still hold? Replied, post #33 · Analytics › Method validation · 22 Feb 2025 · 2 likes Adding the measurement that post #32 says would settle it. Documented validation is what separates a number from an opinion expressed numerically. That is the whole…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #38 · Practice › Reconstitution · 21 Feb 2025 · 2 likes Choose the concentration so that a typical dose lands on a graduation you can actually read. A dose that falls between two marks on a 1 mL barrel is a dose you will get…
-
Consistent declarations and why they matter more than clever ones Replied, post #43 · Sourcing › Logistics · 17 Feb 2025 · 30 likes On post #41 — agreed on the reasoning, with one qualification. Anyone deciding whether a delay is a problem should ask what would change if they waited another week.…
-
When to suspect the method rather than the sample Replied, post #82 · Analytics › Method validation · 15 Feb 2025 · 3 likes Answering the question post #78 raises rather than the one it answers. Range and working range are different things and a certificate rarely distinguishes them. The…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #45 · Devices › Cold chain · 1 Feb 2025 · 5 likes A temperature indicator that has tripped tells you a threshold was crossed. It does not tell you for how long, and duration is most of what determines whether anything…
-
Reading an MS report that only gives you a single number Replied, post #3 · Analytics › Mass spectrometry · 30 Jan 2025 · 24 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Reading a supplementary appendix and finding the interesting part Replied, post #55 · Evidence › Trials · 29 Dec 2024 · 0 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
-
Building a sensible monitoring schedule with your prescriber Replied, post #99 · Clinical › Bloodwork · 22 Dec 2024 · 30 likes Confirming post #96 from a second method, which matters more than confirming it from a second person. Glycaemic markers integrate over different periods. A point…
-
Body image changing more slowly than the body Replied, post #49 · Wellbeing › Mental health · 16 Dec 2024 · 0 likes Identity and self-image: for some people, weight and body size are central to identity. Large change to body size can affect identity. This is not pathological; it is…
-
Coming back to: When to suspect the method rather than the sample Replied, post #60 · Analytics › Method validation · 12 Dec 2024 · 16 likes Limits of detection and quantitation: LOD is the lowest concentration that produces a signal above background. LOQ is the lowest concentration at which the method meets…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #41 · Access › Insurance & coverage · 25 Nov 2024 · 2 likes Coming back to post #40, because the follow-up matters more than the original answer. Prior authorisation: pre-approval requirements and how to satisfy them. Most…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #38 · Compounds › Tirzepatide · 15 Nov 2024 · 0 likes Noted, and thank you for writing it out rather than summarising it.
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #86 · Compounds › Other compounds · 1 Nov 2024 · 2 likes I read post #82 twice before replying, because I had assumed the opposite. One caution on Melanocortin agonists: everything above assumes the underlying documentation…
-
Melanocortin agonists: mechanism and the documented adverse profile Replied, post #9 · Compounds › Other compounds · 25 Oct 2024 · 13 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
Promotion criteria, and the one that stops most nominations Replied, post #81 · Documentation › Doc review · 9 Oct 2024 · 0 likes On promotion criteria I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and conflating them is how…
-
Why our vendor pages link the storefront and mark it sponsored Replied, post #9 · Sourcing › Vendor reports · 2 Oct 2024 · 15 likes Post #8 is the version of this I will quote in future. One addition. The question underneath vendor pages link the storefront is usually "how would I tell?" rather than…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #3 · Wellbeing › Mental health · 23 Sep 2024 · 3 likes Nothing here is medical advice and several members in this subcategory say plainly that they are describing their own experience only. I have changed my mind on this…
-
Second pass at: Reimbursement variation across member states Replied, post #2 · Regional › European Union · 19 Aug 2024 · 0 likes Spain: AEMPS is the regulator. Public reimbursement for weight management has been limited with regional variation in specialist pathways. Private prescription is…
-
Blind submission and why it changes minds Replied, post #23 · Sourcing › Independent verification · 27 Jul 2024 · 0 likes Answering the question post #19 raises rather than the one it answers. The strongest argument against my own position on blind submission, stated as well as I can state…
-
Guidelines revision: what changed and why Replied, post #25 · Meta › Announcements · 25 Jul 2024 · 20 likes Post #21 describes the usual case. This is about the unusual one. Archives: older announcements are archived by date. Checking archives is useful if you want to know…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #37 · Compounds › Retatrutide · 18 Jul 2024 · 0 likes The most useful reply I ever got about Retatrutide dose escalation was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #68 · Practice › Dosing & titration · 8 Jul 2024 · 32 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…